Goldman Sachs Upgrades Seattle Genetics (SGEN) to Neutral

September 15, 2016 6:52 AM EDT
Get Alerts SGEN Hot Sheet
Price: $58.53 -0.44%

Rating Summary:
    6 Buy, 10 Hold, 9 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 24 | Down: 17 | New: 14
Trade SGEN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Goldman Sachs upgraded Seattle Genetics (NASDAQ: SGEN) from Sell to Neutral with a price target of $47.00 (from $30.00).

For an analyst ratings summary and ratings history on Seattle Genetics click here. For more ratings news on Seattle Genetics click here.

Shares of Seattle Genetics closed at $54.06 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst PT Change, Upgrades

Related Entities

Goldman Sachs

Add Your Comment